Sign in
Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial
Journal article   Open access  Peer reviewed

Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial

Joanne Mortimer, Jack Di Palma, Kendra Schmid, Yining Ye and Mohammad Jahanzeb
Breast cancer research : BCR, Vol.21(1), pp.32-32
2019
PMCID: PMC6391844
PMID: 30813966

Abstract

Diarrhea Early-stage breast cancer Health-related quality of life HER2 positive Neratinib Pan-HER inhibition Patient-reported outcomes
url
https://doi.org/10.1186/s13058-019-1112-5View
Published (Version of record) Open

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.119 Breast Cancer Scanning
1.119.259 HER2
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details